Validation of the Adaptive Cognition and Behaviors-6 (ACBS-6) Scale in Individuals with Insomnia and Its Association with Sleep- Related Safety Behaviors

Why It Matters

The validated ACBS‑6 provides clinicians and researchers a concise tool to assess protective sleep cognitions and behaviors, enabling targeted interventions that can reduce insomnia severity and mitigate harmful safety practices.

Key Takeaways

• ACBS‑6 validated with two-factor structure in 600 insomnia participants
• Scale shows negative correlation (r = -0.15) with insomnia severity
• Positive correlations: DBAS‑6 (r = 0.47) and SRBQ‑10 (r = 0.49)
• ACBS‑6, DBAS‑6, SRBQ‑10 together explain 32% variance in insomnia severity
• Adaptive cognition and behavior partially mediate dysfunctional beliefs' impact

Pulse Analysis

Insomnia remains a pervasive public‑health challenge, affecting roughly 10% of U.S. adults chronically. While pharmacologic and behavioral therapies exist, clinicians often lack brief, psychometrically sound instruments to capture the protective side of sleep‑related cognition and behavior. The Adaptive Cognition and Behaviors about Sleep‑6 (ACBS‑6) was designed to fill that gap, offering a six‑item measure that assesses how individuals think about and act on sleep in ways that promote recovery rather than perpetuate distress.

In a recent online study of 600 self‑identified insomniacs, the ACBS‑6 underwent rigorous testing using both classical and modern psychometric techniques. Confirmatory factor analysis identified two distinct yet related dimensions—adaptive cognition and adaptive behavior—each loading strongly on all items. Item‑response theory confirmed high discrimination across the latent trait, though items 3 and 4 contributed less information. Correlational analysis showed the scale inversely related to insomnia severity (r = ‑0.15) while aligning positively with established measures of dysfunctional beliefs (DBAS‑6) and safety behaviors (SRBQ‑10). A regression model incorporating ACBS‑6, DBAS‑6, and SRBQ‑10 explained 32% of the variance in insomnia severity, and mediation testing revealed that adaptive cognitions and behaviors partially offset the harmful impact of maladaptive beliefs.

For practitioners, the ACBS‑6 offers a rapid screening tool that can inform personalized treatment plans, such as cognitive‑behavioral therapy for insomnia (CBT‑I) modules focused on reshaping sleep‑related thoughts and habits. Researchers can also leverage the scale to track changes over time or evaluate the efficacy of novel interventions. As the field moves toward precision sleep medicine, instruments like the ACBS‑6 will be essential for distinguishing protective factors from risk factors, ultimately guiding more effective, data‑driven care.